Medtronic (MDT) Tops Q1 EPS by 2c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report
August 26, 2016 10:42 AM EDTJefferies reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $100.00 (from $93.00), following the company's 1Q earnings report. EPS was reported $0.02 above estimates. FX was only $7mn v. the $25- $75mn guided to and the company missed consensus by about... More
Oppenheimer Raises Price Target on Medtronic (MDT) to $94 Following EPS Beat
August 26, 2016 9:44 AM EDTOppenheimer reiterated an Outperform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $94.00 (from $90.00), following the company's 1Q earnings report. MDT reported a $0.02 EPS beat, driven by a slightly lower interest expense and tax rate.
Analyst Steven Lichtman commented,... More
UBS Reiterates Buy on Medtronic (MDT) Following 1Q Report
August 26, 2016 8:55 AM EDTUBS reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $96.00 (from $92.00), following the company's 1Q earnings report. Management reiterated F17 guidance of 5-6% top-line adjusted CC growth and EPS guidance of $4.60-4.70.
Analyst Matt Miksic commented, "Management delivered on its F1Q17 guidance of 5.0 5.5% adjusted... More
